908 Devices

908 Devices Gross Profit

The Gross Profit of 908 Devices (MASS) as of Nov 5, 2026 is 26.80 M USD. In the previous year, Gross Profit was 29.93 M USD — a change of -10.45% (lower).

Gross Profit

26.80 MUSD

YoY

-10.45%

Last updated:

Gross Profit of 908 Devices is 2025 26.80 M USD. Gross Profit of 908 Devices was 2024 29.93 M USD. It decreases by -10.45% lower compared to the previous year.

The 908 Devices Gross Profit history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Profit
Date
Gross Profit
Jan 1, 2018
12.39 M USD
Jan 1, 2019
8.14 M USD
Jan 1, 2020
14.92 M USD
Jan 1, 2021
23.23 M USD
Jan 1, 2022
26.02 M USD
Jan 1, 2023
25.32 M USD
Jan 1, 2024
29.93 M USD
Jan 1, 2025
26.80 M USD
The 908 Devices Gross Profit history
YEARGross ProfitYoY
26.80 MUSD-10.45%
29.93 MUSD+18.18%
25.32 MUSD-2.69%
26.02 MUSD+12.01%
23.23 MUSD+55.69%
14.92 MUSD+83.26%
8.14 MUSD-34.29%
12.39 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

908 Devices Revenue

908 Devices Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
46.72 M USD
-35.38 M USD
-31.74 M USD
Jan 1, 2023
49.97 M USD
-42.76 M USD
-36.40 M USD
Jan 1, 2024
59.63 M USD
-76.72 M USD
-72.21 M USD
Jan 1, 2025
56.20 M USD
-24.18 M USD
-36.64 M USD
Jan 1, 2026 (e)
69.17 M USD
-35.64 M USD
-33.20 M USD
Jan 1, 2027 (e)
82.54 M USD
-16.18 M USD
-16.72 M USD
Jan 1, 2028 (e)
97.54 M USD
-9.08 M USD
-8.50 M USD
Jan 1, 2029 (e)
101.80 M USD
-7.72 M USD
-7.24 M USD

908 Devices Margins

908 Devices stock margins

The 908 Devices margin analysis displays the gross margin, EBIT margin, as well as the profit margin of 908 Devices. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for 908 Devices.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2022
55.70 %
-75.73 %
-67.94 %
Jan 1, 2023
50.68 %
-85.57 %
-72.85 %
Jan 1, 2024
50.18 %
-128.65 %
-121.09 %
Jan 1, 2025
47.68 %
-43.03 %
-65.20 %
Jan 1, 2026 (e)
47.68 %
-51.52 %
-48.00 %
Jan 1, 2027 (e)
47.68 %
-19.61 %
-20.26 %
Jan 1, 2028 (e)
47.68 %
-9.31 %
-8.72 %
Jan 1, 2029 (e)
47.68 %
-7.58 %
-7.11 %

908 Devices Stock analysis

What does 908 Devices do? The company 908 Devices was founded in Boston in 2012 and specializes in the development and manufacturing of innovative analysis devices. The idea behind the company was to develop portable devices that would allow users to perform quick and accurate analyses on-site. 908 Devices' business model is based on the development and marketing of devices for the chemistry, pharmaceutical, and biotech industries, as well as for applications in the security and defense sectors. The company has several product lines tailored to different applications, including portable devices for mobile use. One of the most important branches of 908 Devices is mass spectrometry, a method used in many areas of analytics, such as forensics, environmental analysis, and food control. 908 Devices has developed a technology that allows for compact and portable mass spectrometry, which was not previously possible. Another important area of 908 Devices is chromatography, a method used for separating substances. Here too, the company has developed a technology that allows for the offering of chromatography in portable devices. 908 Devices also offers devices for molecular spectroscopy, including Raman spectroscopy, which allows for the identification and characterization of molecules. Raman spectroscopy is used in many applications, such as pharmaceutical research and material analysis. Among the products offered by 908 Devices are the M908 and MX908 devices, specifically designed for use in the security and defense industry. These devices allow for the real-time detection of a variety of hazardous substances, such as explosives, drugs, or dangerous chemicals. Another product of 908 Devices is the ZipChip device, used in biotech research. The ZipChip allows for the analysis of proteins in a very short time, which is of great importance in pharmaceutical research. The company has received several awards in recent years, including the R&D 100 Award and the Innovation Award of Analytica, one of the world's most important trade fairs for analytics and laboratory technology. Overall, 908 Devices has achieved an impressive success story and aims to revolutionize the way analyses are conducted. With its innovative products and technologies, the company has found a niche in the market and has experienced strong growth. 908 Devices is one of the most popular companies on Eulerpool.

Frequently Asked Questions about 908 Devices stock

Gross Profit of 908 Devices is 26.80 M USD in 2025.

Gross Profit of 908 Devices changed from 29.93 M USD to 26.80 M USD, representing a -10.45% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Profit 908 Devices since 2006 – with annual values, charts, and detailed analysis.

Gross Profit is the revenue remaining after deducting the cost of goods sold. It shows how efficiently a company uses its resources to produce goods or services.

Gross Profit's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Gross Profit's 908 Devices historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — 908 Devices

All Key Metrics — 908 Devices